258 related articles for article (PubMed ID: 32442945)
21. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
[TBL] [Abstract][Full Text] [Related]
22. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR
J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
24. Hypoparathyroidism.
Al-Azem H; Khan AA
Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):517-22. PubMed ID: 22863393
[TBL] [Abstract][Full Text] [Related]
25. [PTH-replacement therapy in hypoparathyroidism : what benefits ?].
Trombetti A; Bégin MJ
Rev Med Suisse; 2021 Apr; 17(735):788-792. PubMed ID: 33881242
[TBL] [Abstract][Full Text] [Related]
26. A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides.
Marcucci G; Brandi ML
Front Horm Res; 2019; 51():165-171. PubMed ID: 30641529
[TBL] [Abstract][Full Text] [Related]
27. The Clinical and Skeletal Effects of Long-Term Therapy of Hypoparathyroidism With rhPTH(1-84).
Agarwal S; McMahon DJ; Chen J; Brossfield AV; Fernando J; Bilezikian JP; Cusano NE; Rubin MR
J Bone Miner Res; 2023 Apr; 38(4):480-492. PubMed ID: 36726204
[TBL] [Abstract][Full Text] [Related]
28. [Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?].
Jurecka-Lubieniecka B; Paliczka E; Czarniecka A; Jarzab M; Handkiewicz D; Hasse-Lazar K; Kukulska A
Endokrynol Pol; 2006; 57(5):501-8. PubMed ID: 17133315
[TBL] [Abstract][Full Text] [Related]
29. Chronic hypoparathyroidism and treatment with teriparatide.
Marcucci G; Masi L; Cianferotti L; Giusti F; Fossi C; Parri S; Gronchi G; Brandi ML
Endocrine; 2021 Apr; 72(1):249-259. PubMed ID: 33538953
[TBL] [Abstract][Full Text] [Related]
30. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Hypoparathyroidism by Re-Establishing the Effects of Parathyroid Hormone.
Rejnmark L
Endocrinol Metab (Seoul); 2024 Apr; 39(2):262-266. PubMed ID: 38572533
[TBL] [Abstract][Full Text] [Related]
32. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
Gonzales MC; Lieb DC; Richardson DW; O'Brian JT; Aloi JA; Khardori RK
Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
[TBL] [Abstract][Full Text] [Related]
34. The Effects of Radioiodine Therapy on the Recovery of Parathyroid Function in Patients with Protracted Hypoparathyroidism after Total Thyroidectomy for Papillary Thyroid Carcinoma.
Abuduwaili M; Baidula W; Xia B; Wu Z; Chen Z; Xing Z; Su A
J Invest Surg; 2023 Dec; 36(1):1-9. PubMed ID: 36410743
[TBL] [Abstract][Full Text] [Related]
35. Hypoparathyroidism - disease update and emerging treatments.
Monis EL; Mannstadt M
Ann Endocrinol (Paris); 2015 May; 76(2):84-8. PubMed ID: 25882889
[TBL] [Abstract][Full Text] [Related]
36. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.
Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M
Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447
[TBL] [Abstract][Full Text] [Related]
37. Postsurgical Hypoparathyroidism: A Systematic Review.
Kakava K; Tournis S; Papadakis G; Karelas I; Stampouloglou P; Kassi E; Triantafillopoulos I; Villiotou V; Karatzas T
In Vivo; 2016; 30(3):171-9. PubMed ID: 27107072
[TBL] [Abstract][Full Text] [Related]
38. Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism.
Edafe O; Mech CE; Balasubramanian SP
Cochrane Database Syst Rev; 2019 May; 5(5):CD012845. PubMed ID: 31116878
[TBL] [Abstract][Full Text] [Related]
39. Management of Hypoparathyroidism: Present and Future.
Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
[TBL] [Abstract][Full Text] [Related]
40. American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults.
Orloff LA; Wiseman SM; Bernet VJ; Fahey TJ; Shaha AR; Shindo ML; Snyder SK; Stack BC; Sunwoo JB; Wang MB
Thyroid; 2018 Jul; 28(7):830-841. PubMed ID: 29848235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
